Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Adam

Showing results (241-250 of 248) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 248 results.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 17, 2025
Description of TEMPI syndrome in Waldenström's macroglobulinemiaZ Adam, L N Leová, M Patočková, et al.
International Journal of Cardiology|May 3, 2016
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary interventionZ Adam, A Turley, J M Mason, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|October 30, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitorsM Štork, J Kotašková, E Ondroušková, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 13, 2011
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myelomaP Kessler, L Pour, E Gregora, et al.
Vnitrni Lekarstvi|April 24, 2002
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma]Z Adam, L Pour, A Svobodník, et al.
Vnitrni Lekarstvi|November 12, 2002
[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years]V Scudla, J Bacovský, K Indrák, et al.
Vnitrni Lekarstvi|November 6, 2001
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]M Krejcí, R Hájek, V Scudla, et al.
Pageof 25

Showing results (241-250 of 248) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 248 results.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 17, 2025
Description of TEMPI syndrome in Waldenström's macroglobulinemiaZ Adam, L N Leová, M Patočková, et al.
International Journal of Cardiology|May 3, 2016
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary interventionZ Adam, A Turley, J M Mason, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|October 30, 2025
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitorsM Štork, J Kotašková, E Ondroušková, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 13, 2011
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myelomaP Kessler, L Pour, E Gregora, et al.
Vnitrni Lekarstvi|April 24, 2002
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma]Z Adam, L Pour, A Svobodník, et al.
Vnitrni Lekarstvi|November 12, 2002
[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years]V Scudla, J Bacovský, K Indrák, et al.
Vnitrni Lekarstvi|November 6, 2001
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]M Krejcí, R Hájek, V Scudla, et al.
Pageof 25